Facial Injectable Market: Current Analysis and Forecast (2022-2028)

Facial Injectable Market: Current Analysis and Forecast (2022-2028)

The Facial injectables market is expected to register a CAGR of approx. 9% over the period of 2022-2028. Facial injectables products are those that are used in facial surgeries and facial rejuvenation. Facial injectables products are primarily used to reduce the signs of aging and enhance aesthetic beauty. It is a substance that is used to reduce wrinkles and restore volume and fullness to the face. It is injected just beneath the surface of the facial skin. Hyaluronic acid, botulinum toxin type A, and polymer fillers are among the most commonly used facial injectables. It smooths and lightens scars and wrinkles on the skin. Facial injectables devices, such as conventional syringes, needle-free injectors, auto, and pen injectors, have been used for drug administration in the treatment of medical conditions, particularly cancer and autoimmune disorders. The growing demand for facial injectables can be attributed to the rise in demand for aesthetic attractiveness enhancement and a preference for minimally invasive procedures across the globe.

For instance, according to the American Society of Plastic Surgeons (ASPS), in the U.S., nearly 18 million minimally invasive and surgical cosmetic products were performed in 2020, out of which nearly 16 million products were minimally invasive. Owing to the glaring statistics the increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of such treatment options across the globe is leading to the growing demand for facial injectables and would contribute to the growth of the market in the forthcoming period as well. In addition, due to an increase in the senior population and the advent of improved facial injectables such as synthetic calcium hydroxylapatite (CaHA) fillers are likely to aid the market growth. Furthermore, the facial injectables market is anticipated to grow on account of the increased demand for improving the appearance of recessed scars, Reconstructing contour deformities in the face, Decrease or removing the shadow of the lower lids. However, some of the restraints in the market including the relative side effects and lack of permanence of facial injectables are impeding the growth of this market all over the world.

• Based on the product, the facial injectables market is segmented into collagen, hyaluronic acid (HA), botulinum toxin type A, calcium hydroxylapatite (CaHA), and polymer fillers. The hyaluronic acid (HA) segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe due to the strong adoption of these product types coupled with the wide application of these fillers.
• Based on the application, the market is fragmented into aesthetics and therapeutics. The aesthetics segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines, to name a few. Factors like growing awareness about aesthetic procedures and rising disposable income are expected to boost the market growth.
• Based on the end-users, the market is fragmented into hospitals, dermatology clinics, and others. The dermatology clinic segment is expected to register high growth rates in the market which is mainly due to the large number of injectable facial procedures being carried out in clinics. Further, the increase in a number of specialty clinics, especially in developing countries, equipped with some of the most innovative technologies and products will mean considerable growth of the segment in the years to come.
• For a better understanding of the market adoption of facial injectables, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the facial injectables industry owing to the higher awareness of aesthetic surgical procedures, technological advancements in cosmetic procedures, the presence of key market players, the increasing geriatric population, and the growing demand for non-invasive aesthetic procedures.
• Some of the major players operating in Ipsen SA, Merz Pharma GmbH & Co. KGaA, Medytox Inc, Anika Therapeutics Inc, Zimmer Biomet, Croma-Pharma GmbH, Bioplus Co. Ltd, Bioaxis Pharmaceuticals, Galderma S.A, Prollenium Medical Technologies among others. Several M&A’s along with partnerships have been undertaken by these players.